COVID-19 transmission and mortality disproportionately affects Black, Hispanic, and Native American populations, says gastrotenterologist Sophhie Balzora (above). Colorectal cancer, too, is wrought with disparities in screening, incidence, and mortality rates among these very same populations.
As we envision our nation slowly clawing our way out of the deepest threats of the pandemic, we must come back to the strategies that have specifically worked to address colorectal cancer disparities, so that the decades’ hard work of closing the disparity gap in colorectal cancer screening, incidence, and mortality is not completely lost.
- See “Impact of COVID-19 on colorectal cancer disparities and the way forward” by Sophie Balzora, MD, from the Division of Gastroenterology and Hepatology, NYU Langone Health, New York, New York on the Endoscopedia website from the American Society for Gastrointestinal Endoscopy (October 19, 2020)
- See the full text of the scientific article “Impact of COVID-19 on colorectal cancer disparities and the way forward” by Sophie Balzora et al.
